stockportfolio.pro
Moderna, Inc. Gross Profit 2016–2025
Moderna, Inc. (MRNA) annual gross profit by fiscal year, computed from SEC filings. Compound growth +3.4%/yr over 9 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $1.08B | 55.3% | -39.3% |
| FY 2024 | $1.77B | 54.8% | -17.8% |
| FY 2023 | $2.15B | 31.5% | -84.4% |
| FY 2022 | $13.85B | 71.9% | -12.7% |
| FY 2021 | $15.85B | 85.8% | +1894.2% |
| FY 2020 | $795.00M | 99.0% | — |
| FY 2019 | — | — | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
| FY 2016 | — | — | — |
Source: Moderna, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Moderna, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeModerna, Inc. — frequently asked questions
What is Moderna, Inc.'s gross profit?
Moderna, Inc. (MRNA) reported gross profit of $1.08B for fiscal year 2025, per its SEC filings.
How has Moderna, Inc.'s gross profit changed over time?
Between fiscal 2016 and 2025, MRNA's gross profit grew at roughly 3.4% per year (compound annual rate), from $795.00M to $1.08B.
Where does this data come from?
Figures are computed from Moderna, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.